Status:
UNKNOWN
Maternal Serum Vascular Endothelial Growth Factor in Pregnant Women With Foetal Growth Restriction
Lead Sponsor:
Beni-Suef University
Conditions:
Foetal Growth Restriction
Eligibility:
FEMALE
20-40 years
Brief Summary
In this study we explore To explore the role of maternal serum vascular endothelial growth factor (VEGF) in pregnancies complicated by foetal growth restriction.
Detailed Description
Small-for-gestational age (SGA) is defined as an estimated foetal weight (EFW) or abdominal circumference (AC) less than the 10th centileand severe SGA as an EFW or AC less than the 3rd centile. Foeta...
Eligibility Criteria
Inclusion
- Age 20-40 years
- Gestational age 28-36 weeks
- Fetal growth restriction
- Patient consents to the procedure.
- BMI 20-30
Exclusion
- Preeclampsia
- Diabetes Mellitus
- Fetal congenital anomalies
Key Trial Info
Start Date :
September 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02245477
Start Date
September 1 2014
End Date
June 1 2021
Last Update
February 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nesreen Abdel Fattah Abdullah Shehata
Cairo, Egypt